Addition of GM-CSF to trastuzumab stabilises disease in trastuzumab-resistant HER2+ metastatic breast cancer patients

BACKGROUND: One of the proposed mechanisms of trastuzumab-induced regression of human epidermal growth factor receptor 2-positive (HER2+) tumours includes facilitation of antibody-dependent cell-mediated cytotoxicity (ADCC). Granulocyte-macrophage colony-stimulating factor (GM-CSF) mediates ADCC. We...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Cheng, Y C, Valero, V, Davis, M L, Green, M C, Gonzalez-Angulo, A M, Theriault, R L, Murray, J L, Hortobagyi, G N, Ueno, N T
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2010
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2990606/
https://ncbi.nlm.nih.gov/pubmed/20877352
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6605918
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados